Cytotoxic T-cell response against steroidogenic acute regulatory protein using DNA vaccination followed by vaccinia virus infection in a mouse adrenal carcinoma model

Hormone and Metabolic Research

Volumn 36, Issue 6, 2004, Pages 411-414

  Reincke, M ^a   Ortmann, D ^b   Hausmann, J ^c   Beuschlein, F ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adrenocortical carcinoma; CTL; Immunotherapy; Mouse; Steroidogenic acute regulatory protein; Tolerance

Indexed keywords

STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ADRENAL CORTEX CARCINOMA; ANIMAL CELL; ANTIGENICITY; CARCINOGENESIS; CELL LINE; CONFERENCE PAPER; CYTOTOXICITY; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE STRAIN; NONHUMAN; PALPATION; PRIORITY JOURNAL; SPLEEN CELL; STEROIDOGENESIS; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH; VACCINATION; VACCINIA VIRUS; VIRUS INFECTION;

ADRENAL GLAND NEOPLASMS; ANIMALS; CARCINOMA; DISEASE MODELS, ANIMAL; IMMUNOTHERAPY; INFECTION; MICE; MICE, INBRED BALB C; PHOSPHOPROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA; VACCINES, VIROSOME; VACCINIA VIRUS;

ANIMALIA; MURINAE; VACCINIA VIRUS; VECTORS;

EID: 3142702760     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814571     Document Type: Conference Paper

References (19)

1. Soreide JA, Brabrand K, Thoresen SO. Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 1992; 16: 663-668
2. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B. Clonal composition of human adrenocortical neoplasms. Cancer Res 1994; 54: 4927-4932
3. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P. Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 2000; 28: 145-152
4. Reincke M, Beuschlein F, Slawik M, Borm K. Molecular adrenocortical tumourigenesis. Eur J Clin Invest 2000; 30 Suppl 3: 63-68
5. Dackiw AP, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg 2001; 25: 914-926
6. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003; 169: 5-11
7. Ahlman H, Khorram-Manesh A, Jansson S, Wangberg B, Nilsson O, Jacobsson CE, Lindstedt S. Cytotoxic treatment of adrenocortical carcinoma. World J Surg 2001; 25: 927-933
8. Zenkert S, Schubert B, Fassnacht M, Beuschlein F, Allolio B, Reincke M. Steroidogenic acute regulatory protein mRNA expression in adrenal tumours. Eur J Endocrinol 2000; 142: 294-299
9. Ortmann D, Hausmann J, Beuschlein F, Schmenger K, Stahl M, Geissler M, Reincke M. StAR-directed immunotherapy protects against tumor growth of StAR expressing Sp2-0 cells in a rodent adrenocortical carcinoma model. Endocrinology 2004; 145: 1760-1766
10. Clark B, Wells J, King S, Stocco D. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994; 269: 28314-28322
11. Rice DA, Kirkman MS, Aitken LD, Mouw AR, Schimmer BP, Parker KL. Analysis of the promoter region of the gene encoding mouse cholesterol side-chain cleavage enzyme. J Biol Chem 1990; 265: 11713-11720
12. Thurner B, Haendle I, Roder C, Dieckmann D, Keikavoussi P, Jonuleit H, Bender A, Maczek C, Schreiner D, von den Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen E, Schuler G. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T-cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 1999; 190: 1669-1678
13. Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, Rolland A, Taquet S, Coquery S, Wittkowski KM, Bhardwaj N, Pineiro L, Steinman R, and Fay J. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res 2001; 61: 6451-6458
14. Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 2002; 99: 1517-1526
15. Heiser A, Coleman D, Dannull J, Yancey D, Maurice MA, Lallas CD, Dahm P, Niedzwiecki D, Gilboa E, Vieweg J. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 2002; 109: 409-417
16. Schott M, Feldkamp J, Lettmann M, Simon D, Scherbaum WA, Seissler J. Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma. Clin Endocrinol (Oxf) 2001; 55: 271-277
17. Schott M, Feldkamp J, Schattenberg D, Seissler J, Scherbaum WA. Dendritic cell immuno-therapy in disseminated parathyroid carcinoma [letter; comment]. Lancet 1999; 353: 1188-1189
18. Schott M, Seissler J, Lettmann M, Fouxon V, Scherbaum WA, Feldkamp J. Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination. J Clin Endocrinol Metab 2001; 86: 4965-4969
19. Schott M, Feldkamp J, Klucken M, Kobbe G, Scherbaum WA, Seissler J. Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination. Cancer Immunol Immunother 2002; 51: 663-668